methylprednisolone oral / Generic mfg. 
Welcome,         Profile    Billing    Logout  

10 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
methylprednisolone oral / Generic mfg.
2019-004433-17: Kawasaki Disease Coronary Artery Aneurysm Prevention trial

Ongoing
3
262
Europe
Prednisolone (Tablet 1mg), Prednisolone (Soluble Tablet 5mg), Prednisolone (Oral Solution 10mg/ml), Human Normal Immunoglobulin (IVIg 100mg/ml), Aspirin (Dispersible Tablet 75mg), Aspirin (Tablets 300mg), Prednisolone (Tablet 5mg), Prednisolone (Tablet 10mg), Prednisolone (Tablet 2.5mg), Prednisolone (Tablet 20mg), Prednisolone (Tablet 25mg), Prednisolone (Tablet 30mg), Methylprednisolone (500mg), Methylprednisolone (1000mg), Human Normal Immunoglobulin (IVIg 50mg/ml), Aspirin (Tablet 75mg), Methylprednisolone (40mg), Methylprednisolone (125mg), Methylprednisolone (2g), B01AC06, Tablet, Soluble tablet, Oral solution, Solution for injection/infusion, Dispersible tablet, Powder and solvent for solution for injection/infusion, Powder for injection, Asaflow (80mg), Aspirine (100mg), Aspegic 100mg, Cardioaspirine (100mg), Solu-Medrol S.A.B. (40mg), Octagam (50 mg/ml) solution for infusion, Octagam 10% solution for infusion, Privigen 100 mg/ml solution for infusion, Iqymune (100mg/mL), Okrido 6mg/ml drank
MRC CTU at UCL, Medical Research Council Clinical Trials Unit at University College London, UNIVERSITY COLLEGE LONDON, MRC Clinical Trials Unit at University College London (UCL), Innovative Medicines Initiative 2 Joint Undertaking, Innovative Medicines Initiative 2, Innovative Medicine Initiative 2 Joint Undertaking
Kawasaki Disease, Kawasaki Disease, Diseases [C] - Cardiovascular Diseases [C14]
 
 
2020-004534-38: A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment

Not yet recruiting
2
300
Europe
DUR-928 30mg, DUR-928 90mg, Methylprednisolone, DUR-928, NDC 59762-0051-1, Concentrate for solution for infusion, Capsule, hard + tablet, Methylprednisolone
DURECT Corporation, DURECT Corporation
Alcoholic hepatitis, Damage to your liver due to drinking too much alcohol over a long period of time, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
IMPACT-2, NCT06215261: An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD

Not yet recruiting
2
79
RoW
Methylone, Placebo
Transcend Therapeutics
Post Traumatic Stress Disorder
12/25
12/25
IMPACT-EXT, NCT06237426: An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD

Enrolling by invitation
2
150
Europe
Methylone
Transcend Therapeutics
Post Traumatic Stress Disorder
05/27
05/27
IMPACT-1, NCT05741710: A Study to Assess the Use of Methylone in the Treatment of PTSD

Recruiting
1/2
79
Europe
Methylone, Placebo
Transcend Therapeutics
Post Traumatic Stress Disorder
12/24
12/24
NCT06209606: Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma

Not yet recruiting
1
30
NA
Ruxolitinib Oral Tablet [Jakafi], Ruxolitinib, Jakafi, Lenalidomide, Revlimid, Methylprednisolone, Depo-Medrol, Solu-Medrol, Methyl Prednisolonate
Oncotherapeutics, Incyte Corporation
Multiple Myeloma
05/26
02/29
KPT-IST-391, NCT06225310: A Trial of Selinexor, Ruxolitinib and Methylprednisolone

Not yet recruiting
1
30
NA
Selinexor, Ruxolitinib, Methylprednisolone
Oncotherapeutics
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
04/27
05/27
NCT06303648: A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects

Recruiting
1
24
RoW
Methylone
Transcend Therapeutics
Post Traumatic Stress Disorder
05/24
05/24
I-RUX-15-04, NCT03110822: A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Checkmark Data from I-RUX study for R/R multiple myeloma
Dec 2022 - Dec 2022: Data from I-RUX study for R/R multiple myeloma
Recruiting
1
134
US
Ruxolitinib Oral Tablet [Jakafi], Ruxolitinib, Jakavi, Lenalidomide, Revlimid, Methylprednisolone, Depo-Medrol, Solu-Medrol, Methyl Prednisolonate
Oncotherapeutics, Incyte Corporation
Multiple Myeloma
09/24
02/27
NCT05668910: Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA

Recruiting
N/A
360
RoW
whole genomic methylation and fragmentation profile analysis of cfDNA
GeneCast Biotechnology Co., Ltd., The First Affiliated Hospital of Air Force Military Medical University (Xijing Hospital)
Gastric Cancer
03/24
03/24

Download Options